Quick Answer
XTL BIOPHARMACEUTICALS LTD reported Total Assets of $8.55 million for the year ending 2024.
- XTL BIOPHARMACEUTICALS LTD showed an increase of +46.4% in Total Assets from 2024 to 2024.
- This data is from XTL BIOPHARMACEUTICALS LTD's annual report (Form 10-K), filed with the SEC on April 30, 2025.
- XBRL data for this metric is available from 2016 to 2024 (10 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 10 years of available data (2016 to 2024), XTL BIOPHARMACEUTICALS LTD's Total Assets has grown by 183.4%.
- Historical annual values: Fiscal year 2024: $8.55 million | Fiscal year 2024: $5.84 million | Fiscal year 2023: $2.43 million | Fiscal year 2022: $4.19 million | Fiscal year 2021: $6.62 million | Fiscal year 2020: $6.50 million | Fiscal year 2019: $7.21 million | Fiscal year 2018: $8.58 million | Fiscal year 2017: $6.59 million | Fiscal year 2016: $3.02 million.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: